Every day, fake medicines find their way into online and physical pharmacies, hospitals, and street markets. This plague knows no borders. In the best case scenario, fake medicines leave patients with no side-effects but also without a cure. In many other cases, however, they can kill people. We have to get smarter than the criminals to put a stop to this silent public health threat.
An interview with Dr Salah-Dine Chibout, Member of EFPIA Research Directors Group
This video illustrates the value of innovation -- both revolutionary and incremental -- in the biopharmaceutical field. With a specific focus on incremental innovation, it explains how the continuous investments in R&D, and consequent advances in available treatments, have bettered the lives of millions patients all around the world.
at the IMI Stakeholder Forum 2013 (FR and EN)
An interview with Stuart Hurst - Chair of Efpia's Coding & Serialisation Oversight Group (Eli Lilly)